Selected Publications

Nikhil Yegya-RamanTimothy P. KegelmanSang Ho LeeMichael J. KallanKristine N. KimJyotsna NatarajanMatthew P. DeekWei ZouShannon E. O’ReillyZheng ZhangWilliam LevinKeith CengelGary KaoRoger B. CohenLova L. SunCorey J. LangerCharu AggarwalAditi P. SinghRupal O’QuinnBonnie KyAditya ApteJoseph DeasyYing XiaoAbigail T. BermanSalma K. JabbourSteven J. Feigenberg: Death without progression as an endpoint to describe cardiac radiation effects in locally advanced non-small cell lung cancer. Clinical and Translational Radiation Oncology 39, March 2023.

Nikhil Yegya-Raman, Steven Feigenberg, John Kucharczuk, Bonnie Ky, Lova Sun: Cardiovascular Risk Mitigation with Lung Cancer Treatment. Current Oncology Reports 25, 2023.

Melina Marmarelis, Lova Sun, Charu Aggarwal: Controversies in Thoracic Oncology: adjuvant atezolizumab should be given to all patients with PD-L1 positive tumors. JTO 2023.

Hobday SB, Brody RM, Kriegsman B, Basu D, Newman J, Cohen RB, Lukens JN, Singh A, D'Avella CA, Sun L.: Outcomes Among Patients With Mucosal Head and Neck Squamous Cell Carcinoma Treated With Checkpoint Inhibitors. JAMA Otolaryngol Head Neck Surg 148: 918-926, Oct 2022.

Sun L, Candelieri-Surette D, Anglin-Foote T, Lynch JA, Maxwell KN, D'Avella C, Singh A, Aakhus E, Cohen RB, Brody RM.: Cetuximab-Based vs Carboplatin-Based Chemoradiotherapy for Patients With Head and Neck Cancer. JAMA Otolaryngol Head Neck Surg Sep 2022.

Lova Sun, MD, MSCE; Melina Marmarelis, MD; and Charu Aggarwal, MD, MPH: First-Line Therapy in Patients With KRAS-Mutated Non–Small Cell Lung Cancer. ASCO Daily News September 2022.

Sun L, Brody R, Candelieri D, Anglin-Foote T, Lynch JA, Maxwell KN, Damrauer S, Ojerholm E, Lukens JN, Cohen RB, Getz KD, Hubbard RA, Ky B: Association Between Up-front Surgery and Risk of Stroke in US Veterans With Oropharyngeal Carcinoma. JAMA Otolaryngol Head Neck Surg. Aug 2022.

Trivedi S, Sun L, Aggarwal C.: Immunotherapy for Head and Neck Cancer. Hematol Oncol Clin North Am Jul 2021.

Sun L, Hsu M, Cohen RB, Langer CJ, Mamtani R, Aggarwal C.: Association Between KRAS Variant Status and Outcomes With First-line Immune Checkpoint Inhibitor-Based Therapy in Patients With Advanced Non-Small-Cell Lung Cancer. JAMA Oncol 7: 937-939, Jun 2021.

Sun L, Shimunov D, Tan EX, Swisher-Mcclure S, Lin A, Lukens JN, Basu D, Chalian AA, Cannady SB, Newman JG, Rajasekaran K, O'Malley BW Jr, Rassekh CH, Weinstein GS, Loevner LA, Aggarwal C, Singh A, Cohen RB, Bauml JM, Brody RM.: Survival and toxicity in patients with human papilloma virus-associated oropharyngeal squamous cell cancer receiving trimodality therapy including transoral robotic surgery. Head Neck Jun 2021.